Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.
Discovering and developing innovative therapeutics for CNS disorders
About Us
Management
Marco Caremi
- Vice President Strategic Marketing and Head of Legal Affairs
After serving as VP, Business Development for 5 years, Marco Caremi has been appointed Company’s Vice President of Strategic Marketing and Head of Legal Affairs since February 2007. He holds a university degree in Natural Science from the University of Milan and has successfully completed the Advanced Development Programme at the London Business School. Mr. Caremi has approximately 25 years of experience in the pharmaceutical industry. From 1998 to 2002, he was the Director of Business Development at Schwarz Pharma S.p.A. where he had responsibility for researching and evaluating all in- and out-licensing deals, analysing companies for potential acquisitions and developing strategic plans for forthcoming market opportunities. From 1996 to 1998, he was the Business Development Manager at Schering-Plough S.p.A. From 1990 to 1996, he held several marketing & sales positions at Schering-Plough S.p.A.. Before that time, he was a sales representative, sales specialist and sales district coordinator at Polifarma S.p.A.".